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Abstract
Background: In many neuroinflammatory diseases, dendritic cells (DCs) accumulate in several compartments of the central
nervous system (CNS), including the cerebrospinal fluid (CSF). Myeloid DCs invading the inflamed CNS are thus thought to
play a major role in the initiation and perpetuation of CNS-targeted autoimmune responses. We previously reported that, in
normal rats, DCs injected intra-CSF migrated outside the CNS and reached the B-cell zone of cervical lymph nodes. However,
there is yet no information on the migratory behavior of CSF-circulating DCs under neuroinflammatory conditions.
Methodology/Principal Findings: To address this issue, we performed in vivo transfer experiments in rats suffering from
experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. EAE or control rats were injected intra-CSF
with bone marrow-derived myeloid DCs labeled with the fluorescent marker carboxyfluorescein diacetate succinimidyl ester
(CFSE). In parallel experiments, fluorescent microspheres were injected intra-CSF to EAE rats in order to track endogenous
antigen-presenting cells (APCs). Animals were then sacrificed on day 1 or 8 post-injection and their brain and peripheral
lymph nodes were assessed for the presence of microspheres
+ APCs or CFSE
+ DCs by immunohistology and/or FACS
analysis. Data showed that in EAE rats, DCs injected intra-CSF substantially infiltrated several compartments of the inflamed
CNS, including the periventricular demyelinating lesions. We also found that in EAE rats, as compared to controls, a larger
number of intra-CSF injected DCs reached the cervical lymph nodes. This migratory behavior was accompanied by an
accentuation of EAE clinical signs and an increased systemic antibody response against myelin oligodendrocyte
glycoprotein, a major immunogenic myelin antigen.
Conclusions/Significance: Altogether, these results indicate that CSF-circulating DCs are able to both survey the inflamed
brain and to reach the cervical lymph nodes. In EAE and maybe multiple sclerosis, CSF-circulating DCs may thus support the
immune responses that develop within and outside the inflamed CNS.
Citation: Hatterer E, Touret M, Belin M-F, Honnorat J, Nataf S (2008) Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical
Lymph Nodes under Neuroinflammatory Conditions. PLoS ONE 3(10): e3321. doi:10.1371/journal.pone.0003321
Editor: Jean Kanellopoulos, University Paris Sud, France
Received August 1, 2008; Accepted September 5, 2008; Published October 2, 2008
Copyright:  2008 Hatterer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from INSERM and ARSEP (to S. Nataf) and by a fellowship from MRT to E. Hatterer. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nataf@lyon.inserm.fr
Introduction
DCs are the most powefull antigen presenting-cells of the immune
system. They sequentially capture antigens in inflamed tissues, reach
the lymphatic vessels, migrate toward lymphoid organs and induce
the antigen-specific proliferation of T-cells [1,2]. However, this
functionalscheme doesnotapplyto CNS forthe following reasons:i)
in contrast with all other tissues, there is no DCs residing in the CNS
parenchyma, ii) the so-called ‘‘blood-brain barrier’’ considerably
limits the penetration of blood-circulating immune cells, including
DCs and their precursors, into the CNS parenchyma; iii) the CNS is
devoided of lymphaticvessels.Nevertheless,despite these limitations,
DCs were shown to infiltrate several compartments of the CNS
under neuroinflammatory conditions. These intra-CNS compart-
ments communicate with each others and comprises: the CSF [3,4],
the meninges [5,6], the perivascular spaces [5,6] and the CNS
parenchyma [6,7]. Due to the lack of intra-CNS lymphatic vessels,
the question whether and how DCs migrate from the inflamed CNS
to lymphoid organs is still controversial. Previous studies performed
in normal rats or mice showed that DCs are able to migrate from
brain to cervical lymph nodes (CLNs) and to elicit a systemic
immune response [8,9]. Also, we reported that in normal rats, DCs
injected into the cerebrospinal fluid reached the CLNs while DCs
injected intothebrainparenchyma stayedconfinedtotheCNS [10].
However, as these experiments were performed in normal rats, one
cannot conclude on the actual behavior of CNS-infiltrating DCs
under neuroinflammatory conditions. In the present paper, we
specifically assessed the migratory behavior and functions of CSF-
circulating DCs (CSF DCs) in a rat model of multiple sclerosis, the
most common autoimmune disorder of the CNS. Two complemen-
tary experimental procedures were followed: i) in a first set of
experiments, we tracked endogenous CSF-circulating antigen-
presenting cells (APCs) by injecting fluorescent microspheres into
the CSF of rats induced for EAE; ii) in a second set of experiments,
bonemarrow-derivedmyeloidDCswerelabeledwiththefluorescent
marker carboxyfluorescein diacetate succinimidyl ester (CFSE) then
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3321injected into the CSF of EAE rats, at the clinical peak of the disease,
or control rats. The brains and peripheral lymph nodes of injected
animals were then examined by immunohistological methods or
FACS analysis on day 1 or 8 post-injection. Data showed that in
EAE rats, CSF DCs substantially infiltrated the inflamed brain.
Moreover, CSF DCs reached the cervical lymph nodes and
enhanced the systemic humoral response against myelin oligoden-
drocyte glycoprotein (MOG), a major immunogenic myelin antigen,
Results
Intra-CNS migration of CSF DCs in EAE versus control rats
An immunohistological examination of the CNS was performed
in: i) EAE rats injected intra-CSF with microspheres (n=14) and
sacrificed on day 1 (n=8) or 8 (n=6) post-injection; ii) EAE rats
injected intra-CSF with CFSE-labeled DCs (n=18) and sacrificed
on day 1 (n=8) or 8 (n=10) post-injection; iii) control rats injected
intra-CSF with CFSE-labeled DCs and sacrificed on day 1 post-
injection (n=4) or 8 post-injection (n=3). In EAE rats, all intra-
CSF injections were performed at the clinical peack of disease, on
day 12 post-immunization.
(i) Migration of CSF DCs in the periventricular
parenchyma
In EAE rats injected with microspheres and sacrificed on day 1
post-injection (n=8), phagocytic cells having engulfed fluorescent
microspheres (microspheres
+ cells) were detected as free-floating
cells in the injected lateral ventricle (Fig 1A–D) as well as in the
third ventricle (Fig 1E) and in the fourth ventricle (data not
shown). These microspheres
+ cells expressed OX42 (CD11b/c)
and MHC class II molecules (Fig 1A–C). Also, microspheres
+ cells
harboring the same phenotype were evidenced in periventricular
inflammatory lesions (Fig 1D–E). Similarly, in EAE rats injected
with CFSE-labeled DCs and sacrificed on day 1 post-injection
(n=8), CFSE
+/OX42
+ cells were detected in the ventricular CSF
compartment (Fig 1F–H) and in the periventricular parenchyma
(Fig 1I). A similar distribution of CFSE+/OX42+ cells was
observed in EAE rats injected with CFSE-labeled DCs and
sacrificed on day 8 post-injection (n=10) (Fig 1J). When
performing an immunostaining of the myelin basic protein
(MBP)(Fig 2), we found that microspheres
+ cells (Fig 2A–C) or
CFSE
+/MHC class II
+ DCs (Fig 2D–I) could be evidenced within
periventricular demyelinating lesions, on day 8 (Fig 2A–C) or 1
post-injection (Fig 2D–I). Such a migratory behavior was specific
as the mean number of CFSE
+ DCs was more than 4 times higher
in periventricular demyelinating lesions than in normal-appearing
periventricular white matter (9.4+/22.5 cells/10
22 mm
2 vs 1.6+/
20.5 cells/10
22 mm
2 in demyelinated vs normal-appearing
periventricular white matter respectively, p=0.02, Mann and
Whitney test)(Fig 3A). Interestingly, some of the microspheres
+
cells that localized in these periventricular demyelinating lesions
displayed an intracytoplasmic MBP staining, suggesting they had
ingested MBP-containing myelin debris (Data supplement S1).
Finally, to further determine whether the intra-CNS migration of
CSF DCs is conditionned by the neuroinflammatory environment,
we performed parallel experiments in which CFSE
+ DCs were
injected into the CSF of normal rats (n=4). Rats were sacrificed
on day 1 post-injection and serial sections of the injected lateral
ventricle were examined. CFSE
+ DCs were then counted in order
to establish the respective percentages of intraventricular vs
periventricular CFSE
+ DCs on day 1 following injection (Fig 3B).
The same procedure was applied to EAE rats injected with CFSE-
labeled DCs and sacrificed on day 1 post-injection (n=7). While in
normal rats, 14.5+/20.6% cells localized in the periventricular
parenchyma, we found that in EAE rats more than 40% of the
injected cells localized in the periventricular parenchyma (42+/
27%, p=0.008, Mann and Whitney test).
Altogether these data show that in EAE rats as compared to
controls, CSF DCs present an increased ability to penetrate the
periventricular parenchyma and, in particular, the demyelinating
lesions that are adjacent to ventricles.
(ii) Migration of CSF DCs along the deep penetrating
meninges
On day 1 or 8 following injection, numerous microspheres
+ cells
were evidenced in the superficial meninges covering the outer surface
of the brain (data not shown). However, microspheres
+ cells were also
frequently detected in the deep penetrating meninges (Fig 4). In
particular,microspheres+cellslocalized along thepia matter covering
the molecular layers of the cerebellum (Fig 4A–B) or lining the inner
surface of the brainstem (data not shown). These microspheres+ cells
expressed MHC class II molecules (Fig 4C–E) and OX42 (data not
shown). Similarly, on day 1 post-injection, numerous CFSE
+ DCs
were evidenced in the deep penetrating meninges (Fig 4C, D). As
observed for microspheres
+ cells, CFSE
+ DCs were frequently
detected in the meninges covering the molecular layers of the
cerebellum (data not shown) or in the meninges lining the inner
surface of the brainstem (Fig 4F–G).These cellsexpressed MHC class
II molecules and OX42 (Fig 4H–J and data not shown). However, on
day 8 following injection, only few CFSE
+ cells were still detectable in
the deep penetrating meninges (data not shown). Interestingly, when
CSFE
+ DCs were injected into the CSF of normal rats, we could not
detect CFSE
+ cells in the deep penetrating meninges (Table 1).
(iii) Migration of CSF DCs in the brain parenchyma and
perivascular spaces
On day 1 or 8 post-injection, microspheres
+/MHC class II
+ cells
as well as CFSE
+ DCs localized in parenchymal areas, distant away
from the site of injection (Fig 5 and 6). In some cases, these cells
appeared to infiltrate a non-inflamed parenchymalarea as judged by
the lack of infiltrating MHC class II
+ or OX42
+ inflammatory cells
(Fig 5A–C). In other cases, CSF-derived DCs were clearly localized
within parenchymal inflammatory foci. (Fig 5D–I). Interestingly,
microspheres
+/MHC class II
+ cells or CFSE
+ DCs were demon-
strated in perivascular infiltrates (Fig 6). Indeed, as early as day 1
post-injection, microspheres
+/MHC class II
+ cells or CFSE
+/MHC
class II
+ DCs were detected in close vicinity with the vascular wall of
cuffed vessels (Fig 6A–D) including small caliber venules (Fig 6B,
arrow). A similar migratory pattern was observed on day 8 post-
injection (Fig 6E–F). In comparison, only a few CFSE
+ cells were
detected in the perivascular spaces of normal rats injected with
CFSE
+ DCs (Table 1).
Migration of CSF DCs in the cervical lymph nodes
A histological examination of the cervical lymph nodes and
axillary lymph nodes was performed in EAE rats injected intra-
CSF with microspheres (n=14) and sacrificed on day 1 (n=8) or 8
(n=6) post-injection. On day 1 or 8 following injection,
fluorescent microspheres were evidenced in the cervical lymph
nodes (CLNs) (Fig 7A–B) but not in the axillary lymph nodes
(Fig 7E–F) of EAE rats. Microspheres preferentially localized in
the B-cell area of CLNs and could be demonstrated within the
germinal centers of B-cell follicles (Fig 7G). In order to formally
confirm that microspheres had not been passively transported in
the lymph flux, an ultrastructural analysis of CLNs was performed.
This allowed microspheres to be demonstrated in the cytoplasm of
phagocytic cells that localized in the B-cell areas of CLNs (Fig 7H).
Traffic of CSF Dendritic Cells
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3321Figure 1. CSF-circulating DCs infiltrate the periventricular parenchyma. Fluorescent microspheres or DCs labeled with the cytoplasmic
fluorescent marker CFSE wereinjectedinto theleft lateral ventricleofEAE rats (n=32) atthe clinical peak ofdisease (day 12post-immunization).EAErats
injected with fluorescent microspheres (n=14) or CFSE-labeled DCs (n=18) were then sacrificed on day 1 post-injection (n=16) or 8 post-injection
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toward the CLNs, a FACS analysis was performed on the lymph
nodes of EAE rats (n=8) or control rats (n=7) injected intra-CSF
with CFSE
+ DCs (Fig 8). In injected EAE rats sacrificed on day 1
post-injection (n=4), we found that 2.26+/20,11% CFSE
+ cells
could be detected in the CLNs as compared to 1.37+/20,03% in
the axillary lymph nodes (p=0.02, Mann and Whitney
test)(Fig 8A, C–D). However, in injected EAE rats sacrificed on
day 8 post-injection (n=4), no statistical difference was observed
between the CLNs and the axillary lymph nodes regarding the
Figure 2. CSF-circulating DCs penetrate periventricular demyelinating lesion. Fluorescent microspheres or DCs labeled with the
cytoplasmic fluorescent marker CFSE were injected into the left lateral ventricle of EAE rats (n=32) at the clinical peak of disease (day 12 post-
immunization). EAE rats injected with fluorescent microspheres (n=14) or CFSE-labeled DCs (n=18) were then sacrificed on day 1 post-injection
(n=16) or 8 post-injection (n=16). An immunohistological analysis of brains obtained from injected EAE rats or control healthy rats (n=4) was then
performed using antibodies directed against MHC class II molecules and/or myelin basic protein (MBP). A–C: In a normal rat (A), immunostaining of
MBP (green) is homogenous and symmetric in the periventricular parenchyma adjacent to the third ventricle. In contrast, a large periventricular
demyelinated area, adjacent to the third ventricle, is observed in an EAE rat injected intra-CSF with microspheres and sacrificed on day 8 post-
injection (B). This demyelinating lesion is filled with microspheres
+ cells (C). D–F: On day 1 post-injection, an area of periventricular infiltration
adjacent to the injected lateral ventricle (D) is demyelinated (E) and contains CFSE
+ DCs (F). G–I: On day 1 post-injection, periventricular parenchymal
infiltrates (G) adjacent to the injected lateral ventricle are formed by MHC class II
+ cells (H) and contain MHC class II
+/CFSE
+ DCs (I). LV: lateral ventricle,
V3: third ventricle. Scale bars: 50 mm (A–I).
doi:10.1371/journal.pone.0003321.g002
(n=16). Animmunohistological analysis ofbrainswas then performedusingantibodies directedagainstCD11b/CD11c(OX42)orMHCclassIImolecules.
A–C: OX42
+ cells (green) harboring intracytoplasmic fluorescent microspheres (red) are observed in the lumen of the injected lateral ventricle, on day 1
post-injection. D: Microspheres
+/OX42
+ cells localize in the periventricular parenchyma of the injected ventricle, on day 1 post-injection. Insert (solid
square) shows a high magnification view of microspheres
+/OX42
+ cells infiltrating a periventricular inflammatory lesion (dashed square). E: On day 1
post-injection, MHC class II
+ cells (green) harboring intracytoplasmic fluorescent microspheres (red) are detectable in the lumen of the third ventricle
(dashed square) and in a large periventricular area infiltrated with MHC class II
+ cells. Insert (solid square) shows a high magnification view of
microspheres
+/MHCclassII
+cellsthat localizeinthelumenofthethirdventricle(dashedsquare).Arrowsindicatemicrospheres
+/MHCclassII
+cellsinthe
periventricular parenchyma. F–H: CFSE
+ DCs (green) that express OX42 (red) are detected in the lumen of the injected lateral ventricle, on day 1 post-
injection. I: A periventricular area bordering the injected lateral ventricle is infiltrated by OX42
+ cells and contains OX42
+/CFSE
+ DCs, on day 1 post-
injection. J: On day 8 post-injection, CFSE
+ DCs are observed in a periventricular inflammatory lesion, adjacent to the injected lateral ventricle. LV: lateral
ventricle, V3: third ventricle. Scale bars: 100 mm (B–J), 50 mm (A–C, E–I), 10 mm (inserts in panel D and E).
doi:10.1371/journal.pone.0003321.g001
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+ cells (Fig 8B). It has to be noticed that a
dilution effect may have partly biased these results as cellularity
increases in the CLNs during the course of EAE (data not shown).
It is also noteworthy that in the CLNs, a majority of CFSE
+ cells
were MHC class II
+ on day 1 or 8 post-injection (Fig 8E–F). This
suggests that in the CLNs, the phenotype of injected cells is stable
over time, at least regarding the expression of MHC class II
molecules.
The presence of CFSE
+ cells, as assessed by FACS analysis, was
then compared in the CLNs of injected EAE rats (n=8) vs injected
control rats (n=7) on day 1 or 8 post-injection. Data showed that
on day 1 post-injection, a greater pourcentage of CSFE
+ cells was
detectable in the CLNs of injected EAE rats (n=4) as compared to
injected control rats (n=3) (2.26+/20.11% vs 1.49+/20.13% in
EAE and control rats respectively, p=0.03, Mann and Whitney
test) (Fig 8G). Again, this difference did not reach significance on
day 8 post-injection (Fig 8H).
Overall, these results show that CSF-circulating APCs rapidly
and specifically target the CLNs under neuroinflammatory
conditions. This process is, at least partly, dependent on the
immune processes that take place in the CNS and the CLNs.
Effects of intra-CSF injection of DCs on EAE outcome
The clinical course of EAE was compared between control EAE
rats, EAE rats injected intra-CSF with microspheres and EAE rats
injected intra-CSF with CFSE-labelled DCs As shown in Figure 9,
we observed that in the time period between day 12 (intra-CSF
injections) and day 20 (sacrifice), EAE rats injected with DCs
(n=10) presented higher clinical scores (cumulative clinical score:
22.25+/21.4) than EAE control rats (n=11, cumulative clinical
score: 17.45+/27.09, p=0.04 as compared to EAE rats injected
with DCs, Student’s t test) or EAE rats injected with microspheres
(n=6, cumulative clinical score: 14.83+/21.6; p=0.002 as
compared to EAE rats injected with DCs, Student’s t test). We
then attempted to determine whether intra-CSF injections of DCs
had induced an increased peripheral immune response against
CNS antigens. As microspheres
+ CSF-derived APCs targeted the
B-cell follicles of CLNs, we focused our analysis on the B-cell
response against CNS antigens. On day 20 post-immunization,
blood samples were withdrawn from control EAE rats (n=4) or
EAE rats that had been injected intra-CSF with DCs on day 12
post-immunization (n=4). Sera were then assessed by Western
blot or ELISA for the presence of antibodies directed against CNS
antigens. We first profiled the serum antibody repertoire against
whole spinal cord antigens, using Western blot analysis (Fig 10A).
Data showed that, as compared to control EAE rats, sera from
injected EAE rats contained higher concentrations of antibodies
directed against a 28 Kda protein, distinct from myelin basic
protein (MBP). As myelin oligodendrocyte glycoprotein, a major
immunogenic myelin antigen, is a 28 Kda molecule [11], we then
performed ELISA experiments to determine the serum concen-
trations of anti-MOG antibodies (Fig 10B). The concentration of
antibodies directed against the MOG peptide 35–55 was greatly
increased in injected EAE rats as compared to control EAE rats
(84.23+/222.8 ng/ml vs 20.53+/24.1 ng/ml in EAE and control
rats respectively, p=0.02, Mann and Whitney test) (Fig 10B). Such
an increased antibody response was not observed when consider-
ing myelin basic protein (MBP) as a target antigen (Fig 10C).
Overall, these data demonstrate that injection of DCs into the CSF
of EAE rats induces an exacerbation of clinical signs along with an
increased systemic antibody response against MOG.
Discussion
The use of fluorescent microspheres to track endogeneous APCs
has been commonly used to analyze the migratory behavior of
DCs in other tissues than the CNS [1,12]. In our experimental
settings, however, one has to consider that microspheres may not
have been exclusively taken up by CSF-circulating APCs. Indeed,
free microspheres may have penetrated into the inflamed CNS
parenchyma before being phagocytized. Nevertheless, several
observations which were performed on day 1 post-injection, that is
Figure 3. CFSE
+ DCs specifically target the periventricular demyelinating lesions. DCs labeled with the cytoplasmic fluorescent marker
CFSE were injected into the left lateral ventricle of healthy control rats or EAE rats at the clinical peak of disease (day 12 post-immunization). Rats were
then sacrificed on day 1 post-injection (EAE rats: n=4, normal rats: n=4) and an immunohistological analysis was performed on brain sections
crossing the injected lateral ventricle. At least 3 to 5 sections per animal were examined. A: In brain sections from EAE rats, an immunostaining of the
myelin basic protein (MBP) was performed and the number of CFSE
+ cells/10
22 mm
2 was counted in demyelinated vs normal-appearing
periventricular white matter, as described in the Materials and Methods section. Data show that the mean number of CFSE
+ cells was more than 4
times higher in periventricular demyelinating lesions than in normal-appearing periventricular white matter (9.4+/22.5 cells/10
22 mm
2 vs 1.6+/
20.5 cells/10
22 mm
2 in demyelinated vs normal-apprearing periventricular white matter respectively, p=0.02, Mann and Whitney test). B:
Intraventricular vs periventricular CFSE
+ cells were counted in brain sections obtained from injected EAE rats or injected control rats. Data are
presented as percentages of intraventricular vs periventricular cells. Results show that in normal rats, 14.5+/20.6% cells localized in the
periventricular parenchyma, while, in EAE rats, more than 40% of the injected cells localized in the periventricular parenchyma (42+/27%, p=0.008,
Mann and Whitney test). Conversely, 85.5+/20.6% CFSE
+ cells localized in the intraventricular lumen of normal rats while less than 60% of the
injected cells localized in the intraventricular lumen of EAE rats (58+/27%, p=0.008, Mann and Whitney test). *: p,0.05, **: p,0.01.
doi:10.1371/journal.pone.0003321.g003
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PLoS ONE | www.plosone.org 5 October 2008 | Volume 3 | Issue 10 | e3321Figure 4. CSF-circulating DCs migrate along the deep penetrating meninges. Fluorescent microspheres or DCs labeled with the
cytoplasmic fluorescent marker CFSE were injected into the left lateral ventricle of EAE rats (n=32) at the clinical peak of disease (day 12 post-
immunization). EAE rats injected with fluorescent microspheres (n=14) or CFSE-labeled DCs (n=18) were then sacrificed on day 1 post-injection
(n=16) and an immunohistological analysis of brains was performed using antibodies directed against CD11b/CD11c (OX42) or MHC class II
molecules. Nuclei were counterstained with the fluorescent nuclear dye DAPI. A, B: Counterstaining of nuclei with DAPI coloration (A) shows that
microspheres
+ cells (visualized as white spots in B) localize in the deep penetrating meninges lining the inner parts of the brainstem (Bs) and
cerebllum (Cb). C–E: Microspheres
+ cells (white in D, red in E) expressing MHC class II molecules (green in C and E) are observed in the deep
penetrating meninges covering the cerebellar convolutions. Insert in E shows a high magnification view of a ramified microsphere
+/MHC class II
+ cell
Traffic of CSF Dendritic Cells
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interpretation: i) there were very few free microspheres in the
brain of injected EAE rats, ii) microspheres were detected in
parenchymal locations that are distant away from the CSF
compartments, iii) when injected into the lateral ventricle of
normal rats, microspheres did not cross the neuroepithelial layer
bordering the lateral ventricle (data not shown). Besides these
considerations, it is striking to observe that all the results obtained
with the microsphere approach were confirmed, at least
qualitatively, when CFSE-labeled DCs were injected into the
CSF of EAE rats. It appears to us that quantitative differences rely
on the sustained traffic of APCs that likely occurs in the CSF of
EAE rats and which cannot be mimicked by a single intra-CSF
injection of labeled DCs. However, regarding the presence of
microspheres
+ cells in the CLNs, one cannot exclude the
possibility that microspheres have been indeed phagocytized
outside the CNS compartments, in the blood or in the CLNs.
The presence of periventricular inflammatory and demyelinating
lesions is a full hallmark of MS pathology [13]. We found here that
DCs injected into the CSF of EAE rats deeply and specifically
penetrated into periventricular demyelinating lesions. Similarly, in
EAE rats injected intra-CSF with fluorescent microspheres,
periventricular demyelinating lesions contained microspheres
+/
MHC class II
+ cells, that putatively derived from the CSF. These
observations show that, in EAE rats, CSF-circulating DCs are
chemoattracted toward such lesions. In all likelihood, these CSF-
derivedDCssampleantigenslocally.However,whether theypresent
antigen to T-cells in situ or in the cervical lymph nodes remains to be
established. In this regard, it has to be noticed that DCs injected into
the brain parenchyma of normal rats migrate little from their site of
injection and do not reach the CLNs [10]. This suggests that,
similarly, DCs entering the inflamed CNS parenchyma may exert
their APC functions in situ. Supporting this view, a recent work
showed that in EAE mice, blood-derived myeloid DCs infiltrate
demyelinating lesions then capture and present myelin antigens in
situ [6].
Another interesting observation is the particular ability of CSF-
circulating DCs to infiltrate the deep penetrating meninges of the
inflamed brain. The pia-matter not only covers the hemispheric
and cerebellar cortical convolutions, but it lines deep cerebral
structures such as the hippocampus or the inner part the
brainstem. The pre- and post-capillary vessels are also covered
by the pia matter, which thus connects the CSF compartment with
the perivascular spaces (Virchow-Robin spaces) [14]. Our data
indicate that the pia matter is a major route of traffic for CSF-
circulating DCs. In this view, it has to be noticed that meninges
have been described as an important site of antigen-presentation
and/or B-cell proliferation in EAE or MS [15,16,17]. The
molecular mechanisms supporting the migration of CSF-DCs
along the pia matter have to be clarified. One may hypothesize
that chemokines accumulate specifically in the CSF compartment
delineated by the penetrating pia-matter. Alternatively, leptome-
ninengeal cells themselves may secrete chemokines [18]. One may
speculate that such a peculiar routage via the pia-matter may allow
CSF-DCs: i) to sample soluble antigens that are drained from the
interstitial fluid of CNS parenchyma [19,20,21], ii) to eventually
reach intra-parenchymal locations that are distant away from the
ventricles, iii) to target the perivascular spaces of post-capillary
venules, where T-cells preferentially infiltrate the CNS [14].
The intra-CSF injection of DCs in EAE rats induced an
exacerbation of clinical signs and an increased systemic antibody
response against MOG. Interestingly, in different EAE models
developed in rats, mice or monkeys, anti-MOG antibodies are
considered as highly pathogenic [22,23,24,25]. Similarly, in MS
patients, anti-MOG antibodies were evidenced in the serum, CSF
and, most importantly, within CNS inflammatory lesions [22,26].
Based on these results, one may assume that in EAE rats injected
with DCs, increased concentrations of serum anti-MOG antibod-
ies may be partly responsible for the aggravation of clinical signs.
Moreover, that intra-CSF injected DCs enhanced the systemic
antibody response further demonstrates that DCs are able to
migrate from the CSF to the CLNs. Interestingly, preliminary data
indicate that, in EAE rats, a diversification of the antibody
repertoire occurs in the CLNs but not the axillary lymph nodes
(data supplement S2). It is thus thinkable that, when targeting the
B-cell area of CLNs, DCs injected intra-CSF induce an
amplification of the anti-MOG antibody response that develops
in the CLNs. Supporting this view, a sub-population of DCs was
previously evidenced in the B-cell zone of lymphoid organs
[27,28,29] and DCs were shown to support the proliferation/
differentiation of B-cells [29,30]. Besides the effects of DCs on B-
Table 1. Semi-quantitative distribution of CSF-injected CFSE
+
DCs in the CNS of normal or EAE rats.
CNS compartment Normal rat EAE rat
Perivascular +/2 +
Intraventricular
Free-floating +++ +++
Adherent to choroid plexuses +++ +++
Periventricular
LV + (SVZ) +++
V3 +/2 ++
V4 +/2 ++
Brain meninges
Superficial +++ +++
Penetrating 2 ++
Cerebellum meninges
Superficial +++ +++
Penetrating 2 +++
Cerebellum parenchyma 2 +
Brain stem parenchyma 2 +
In parallel experiments, DCs labeled with the cytoplasmic fluorescent marker
CFSE were injected intra-CSF to normal rats (n=7) or EAE rats (n=8). Serial
brain sections crossing different brain areas (anterior brain, midbrain, brain
stem and cerebellum) were then assessed for the presence of CFSE
+ cells, on
day 1 post-injection (EAE rats: n=4, normal rats: n=4). A semi-quantitative
analysis was performed as follows: 2: none; +/2: occasional cells; +: 2 to 5 cells
per section; ++: 5 to 10 cells per section; +++: .10 cells per section. LV: lateral
ventricle, V3: third ventricle, V4: fourth ventricle, SVZ: subventricular zone.
doi:10.1371/journal.pone.0003321.t001
observed in the penetrating pia matter. F, G: Counterstaining of nuclei with DAPI coloration (F) shows that CFSE
+ cells (G) localize along the pia
matter lining the inner parts of the brainstem (Bs) and cerebellum (Cb). H–J: An OX42
+ infiltrate is observed in the deep penetrating meninges
covering the inner parts of the brainstem (Bs) and cerebellum (Cb) (H). These infiltrating cells comprise CFSE
+ cells (I) that express OX42 (J). Scale bars:
100 mm (F–G), 50 mm (A–E, H–J), 10 mm (insert in panel E).
doi:10.1371/journal.pone.0003321.g004
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triggered by the infiltration of CSF DCs in multiple CNS
compartments, as previously shown in a murine model of EAE [6].
In many neuroinflammatory disorders, the intra-CSF accumu-
lation of immune cells is a major diagnosis criterion. Paradoxically,
little is know about how and where these CSF-circulating cells
migrate, under neuroinflammatory conditions. The present work
unravels the complex migratory behavior of CSF-circulating DCs
in EAE rats. From the ventricular CSF compartment, DCs have
the ability to target the CLNs but also inflammatory lesions that
localize in periventricular areas, in the deep penetrating meninges
and, to a lesser extend, around parenchymal blood vessels. Our
work shows that CSF DCs are thus able to support CNS-targeted
immune responses inside as well as outside the inflamed CNS.
Materials and Methods
Animals
Animal care and procedures have been conducted according to
the guidelines approved by the French regional ethical committee
in animal experimentation (CREEA - agreement number 0108)
and meet the Neuroscience Society guidelines. Eight to ten weeks
old female Dark Agouti rats were obtained from Harlan (Gannat,
France).
Reagents
Murine GM-CSF, human Flt3-L and murine IL-4 were
obtained from Peprotech (Tebu). Mouse monoclonal antibodies
recognizing rat MHC class II molecules (OX6 antibody), rat
Figure 5. CSF-circulating DCs infiltrate the brain parenchyma. Fluorescent microspheres or DCs labeled with the cytoplasmic fluorescent
marker CFSE were injected into the left lateral ventricle of EAE rats (n=32) at the clinical peak of disease (day 12 post-immunization). EAE rats injected
with fluorescent microspheres (n=14) or CFSE-labeled DCs (n=18) were then sacrificed on day 1 post-injection (n=16) and their brains examined by
immunohistology using antibodies directed against CD11b/CD11c (OX42) or MHC class II molecules. Nuclei were counterstained with the fluorescent
nuclear dye DAPI. A–C: Visualization of nuclei with DAPI coloration (A) allows the localization of microspheres (white in B, red in C) to be determined
(dashed squares in A and B). Microspheres are detected in the molecular layer of the cerebellum and localize in the cytoplasm of a MHC class II
+ cell
(C). Insert in C shows a high magnification view of this microspheres
+/MHC class II
+ cell. DAPI coloration (A) and MHC class II staining (C) shows that
there is no detectable inflammatory infiltrate in this area of the cerebellum. D–F: In the brainstem, an intraparenchymal inflammatory infiltrate is
formed by OX42
+ cells (D) and contains a CFSE
+ cell (E) that expresses OX42 (F). G–I: In the brainstem, an area of diffuse infiltration with OX42
+ cells
(G) contains a CFSE
+ cell (H) that expresses OX42 (I). Inserts in G, H and I show high magnification views of this CFSE
+/OX42
+ cell. Scale bars: 100 mm
(A, B), 50 mm (C–I), 10 mm (insert in panel C).
doi:10.1371/journal.pone.0003321.g005
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(MBP), were purchased from Becton Dickinson Biosciences
(Pharmingen). For immuncytochemistry, a fluorescein-conjugated
goat anti-mouse antibody (Alexa Fluor 488 or 546, Molecular
Probes) was used as a secondary antibody.
Generation and characterization of rat bone marrow-
derived DCs
Rat myeloid DCs were generated from whole bone marrow
cultures as previously described [10]. Briefly, rats were sacrificed,
and bone marrow was flushed from femurs and tibias using 10 ml
of DMEM in a 10 ml syringe with a 26-gauge needle. Bone
marrow cells were then re-suspended and passed through a cell
strainer (70 mm pore). Cells were washed once in DMEM (Gibco)
then cultured in 25 cm
2 culture plates at a density of 10
6 cells/ml
in IMDM (Gibco) supplemented with 15% FCS (Fetal Clone II,
Perbio Science) and antibiotics (penicillin/streptomycin, Invitro-
gen). Bone marrow cultures were then grown for 7 days at 37uC,
5% CO2 in the presence of murine GM-CSF (10 ng/ml) and
human Flt-3 ligand (10 ng/ml). By the end of this period, clusters
of non adherent cells had formed that were removed, dispersed
and re-plated in fresh media consisting of DMEM supplemented
with 10% FCS (BioWest), penicillin/streptomycin (Invitrogen),
murine GM-CSF (10 ng/ml) and murine IL-4 (10 ng/ml). After 3
days, large numbers of free-floating cells could be harvested,
washed once in PBS and used for labeling and in vivo experiments.
The phenotype and morphology of injected cells was assessed by
FACS or immunocytology, as previously described [10] (data
Figure 6. CSF-circulating DCs migrate toward intraparenchymal perivascular infiltrates. Fluorescent microspheres or DCs labeled with
the cytoplasmic fluorescent marker CFSE were injected into the left lateral ventricle of EAE rats (n=32) at the clinical peak of disease (day 12 post-
immunization). EAE rats injected with fluorescent microspheres (n=14) or CFSE-labeled DCs (n=18) were then sacrificed on day 1 post-injection
(n=16) or 8 post-injection (n=16). Their brains were then examined by immunohistology using antibodies directed against MHC class II molecules.
Nuclei were counterstained with the fluorescent nuclear dye DAPI. A, B: Two cuffed vessels (dashed square in A) are observed in the brain
parenchyma, distant away from the injected lateral ventricle, on day 1 post-injection. These perivascular infiltrates contain microspheres
+/MHC class
II
+ cells (arrow heads in B). One of the cuffed vessels presents a venule-like morphology (arrow). Inserts in B show high magnification views of these
microspheres
+/MHC class II
+ cells. C, D: In the brainstem, a perivascular infiltrate is formed by MHC class II
+ cells (C) and contains CFSE
+/MHC class II
+
cells (arrow heads in C and D) on day 1 post-injection. Insert in C shows a DAPI coloration of the brainstem area where this cuffed vessel localizes
(arrow in dashed square). E, F: In the hippocampus, on day 8 post-injection, three cuffed vessels harboring a venule-like morphology (white stars in E)
are surrounded by CFSE
+ cells (F). Scale bars: 100 mm (A), 50 mm (B, E, F), 20 mm (C, D).
doi:10.1371/journal.pone.0003321.g006
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dendritic cell phenotype as demonstrated by the detection of
OX42 (CD11b/c), CD11c and MHC class II molecules. Only 25–
35% of cells expressed the co-stimulatory molecule CD86,
indicating that a great majority of cells displayed an immature
DC phenotye. Accordingly, on cytsopin preparations, immunocy-
tological staining of MHC molecules showed that most cells
harbored intracytoplasmic MHC class II vesicles, a hallmark of
immature DCs (data supplement S3).
Cell labelling
DCs were labeled with CFSE (carboxyfluorescein diacetate
succinimidyl ester, Molecular Probes) as previously described [10].
Briefly, cells were washed once in PBS and incubated for 5 min at
Figure 7. CSF-derived microspheres
+ cells target the B-cell zone of CLNs. Fluorescent microspheres were injected into the left lateral
ventricle of EAE rats (n=14) at the clinical peak of disease (day 12 post-immunization). EAE rats were then sacrificed on day 1 post-injection (n=8) or
8 post-injection (n=6) and their cervical lymph nodes and axillary lymph nodes were examined by histological methods. Nuclei were counterstained
with the fluorescent nuclear dye DAPI. A–D: In the cervical lymph nodes, on day 1 (d1)(A, B) or 8 (d8)(C, D) post-injection, microspheres
+ cells
(visualized as white spots) localize preferentially in the cortical, B-cell rich zone. E, F: On day 8 post-injection (d8), there is no detectable
microspheres
+ cell in the axillary lymph nodes. G: On day 8 post-injection (d8), in the cervical lymph nodes, microspheres
+ cells (arrow heads)(red
spots) are observed in a B-cell follicle (arrow heads). H: On day 8 post-injection, analysis of cervical lymph nodes by transmission electron microscopy
(TEM) shows, in the cortical zone, a phagocytic cell containing a latex bead (Lb, dashed square) and localizing in close contact with lymphocytes (Ly).
A high magnification view of this engulfed latex bead (Lb) is shown in the insert (solid square). Scale bars: 100 mm (A–F), 50 mm (G), 1 mm (H).
doi:10.1371/journal.pone.0003321.g007
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PLoS ONE | www.plosone.org 10 October 2008 | Volume 3 | Issue 10 | e3321Figure 8. CSF-circulating DCs target the CLNs. In parallel experiments, DCs labeled with the cytoplasmic fluorescent marker CFSE were injected
into the left lateral ventricle of control rats (n=7) or EAE rats (n=8) at the clinical peak of disease (day 12 post-immunization). Rats were then
sacrificed on day 1 (d1) or 8 (d8) following injections. The cervical lymph nodes (CLNs) and axillary lymph nodes (ALN) were assessed by FACS analysis
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were further incubated for 5 min at 37uC before being washed in
PBS and re-suspended at a dilution of 3.10
4 cells/ml in red phenol-
free DMEM.
Experimental allergic encephalomyelitis
Chronic relapsing EAE was induced in a total of 47 female Dark
Agouti rats, as previously described [31]. Briefly, 0.5 gram guinea
pig spinal cord obtained from Dunkin-Hartley guinea pigs was
homogenized with 3 ml saline and the homogenate was then
emulsified with 3 ml of Difco’s bacto complete Freund’s
adudjuvant (CFA) H37RA supplemented with 15 mg of Myco-
bacterium tuberculosis H37RA (Difco Laboratories, Detroit, MI).
Rats were injected intradermally into each footpad, under
Isoflurane anesthesia, with 0.1 ml of this emulsion. In this EAE
model, clinical signs peak on day 12 post-immunization then
animals partially recover and experience a second relapse. Rats
were weighted and scored daily according to the following clinical
scale: 0=no clinical signs, 1=tail weakness, 2=tail paralysis,
3=incomplete paralysis of one or two hind legs, 4=complete hind
limb paralysis, 5=moribund
Stereotaxic injections of fluorescent microspheres
On day 12 post-immunization, EAE rats (n=14) received an
intracerebroventricular (intra-CSF) injection of sterile latex
fluorescent microspheres diluted 1/1000. All injections were
performed using red-phenol free DMEM as a vehicle. Briefly,
each rat was deeply anesthetized by pentobarbital injection, placed
in a stereotaxic frame and its head tilted slightly by raising the
tooth bar at 5 mm. Ten ml of the solution was then slowly injected
in the left lateral ventricle (stereotaxic coordinates: 1,4 mm lateral
to the bregma and 4,5 mm down from the surface of the skull)
over a period of 3 min, using a Hamilton syringe. The animal
remained in the stereotaxic frame with the needle in place
thereafter for 1 min and the needle was then slowly removed over
a period of 2 min. Following intra-CSF injections, animals were
kept in our animal facility before being sacrificed on day 1 post-
injection (n=8), or on day 8 post-injection (n=6).
Stereotaxic injections of labeled DCs
Following the same protocol than described above, EAE rats
(n=18)wereinjectedintra-CSFwithvehicle(10 ml)containing3.10
5
CFSE-labeled DCs. Animals were then sacrificed on day 1 (n=8) or
on day 8 (n=10) post-injection. In parallel experiments, normal rats
(n=7) were injected intra-CSF with the same preparation of cells
and sacrificed on day 1 (n=4) or 8 (n=3) post-injection.
Histological analysis
On day 1 or 8 after intra-CSF injections of DCs or
microspheres, animals were anesthetized by halothan inhalation
and killed by intraperitoneal injection of an overdose of
pentobarbital sodium (100 mg/kg). Brains, cervical lymph nodes
and axillary lymph nodes were dissected out and frozen in dry-ice.
When needed, frozen tissues were embedded in polyethylene
glycol and cut in 14 mm thick sections with a cryostat. After
fixation in ethanol, sections were rinsed 3 times in PBS then
incubated for 30 min at room temperature with a blocking
solution containing 4% bovine serum albumin (Sigma-Aldrich)
and 10% normal goat serum. Sections were then incubated
overnight at 4uC with mouse monoclonal antibodies directed
against CD11b/CD11c (OX42), MHC class II molecules (OX6)
or myelin basic protein. OX42 (anti-CD11b/CD11c). All primary
antibodies were diluted 1:100 in blocking solution. After several
washes in PBS, sections were incubated for 50 min in blocking
solution containing a fluorescein-conjugated goat anti-mouse
antibody (dilution 1:100) then rinsed in PBS and mounted using
an aqueous preparation (Fluoroprep, BioMe ´rieux). Images were
recorded and analyzed using a computer-assisted system consisting
of specific image analysis software (analysis auto, Soft Imaging
System GmbH, Munster, Germany), coupled to a light and
fluorescent microscope (Zeiss Axioplan II, Oberkochen, Germany)
and in some cases, confocal laser scanning microscopy (LSM
META Zeiss) was performed to discriminated between phagocytic
cells internalization of microspheres and attachment to the cell
membrane. For analysis of fluorescence, two views of the same
sections were recorded, using appropriate filters, as black and
white image, which were then color-coded by software as blue
(DAPI, cell nuclei), green (CFSE or cell type markers) or red
Figure 9. DCs injected intra-CSF aggravates EAE clinical signs.
The clinical course of EAE was compared between control EAE rats
(n=11), EAE rats injected intra-CSF with microspheres (n=6) and EAE rats
injected intra-CSF with CFSE-labeled DCs (n=10). Data show that in the
time period between day 12 (intra-CSF injections) and day 20 (sacrifice),
EAE rats injected with DCs presented higher clinical scores (cumulative
clinical score: 22.25+/21.4) than EAE control rats (cumulative clinical
score: 17.45+/27.09, p=0.0409 as compared to EAE rats injected with
DCs, Student’s t test) or EAE rats injected with microspheres (cumulative
clinical score: 14.83+/21.6; p=0.0020 as compared to EAE rats injected
with DCs, Student’s t test). In contrast, the cumulative clinical scores
observedinEAEcontrolratsandEAE ratsinjectedwithmicrosphereswere
not statistically different. *: p,0.05, **: p,0.01.
doi:10.1371/journal.pone.0003321.g009
for the presence of CFSE
+ cells. The level of autofluorescence was established on cells obtained from the CLNs or ALNs of non-injected EAE rats (n=4)
or control rats (n=3). A–D: In injected EAE rats sacrificed on day 1 post-injection (n=4), we found that 2.26+/20.11% CFSE
+ cells could be detected
in the CLNs as compared to 1.37+/20.03% in the axillary lymph nodes (p=0.0202, Mann and Whitney test)(A). However, in injected EAE rats sacrificed
on day 8 post-injection (n=4), the percentage of CFSE
+ cells was not statistically different between the CLNs and the ALNs (B). Pannels C and D show
representative dot plots obtained from the analysis of injected EAE rats sacrificed on day 1 post-injection. E–F: In the CLNs of injected EAE rats, a
great majority of CFSE
+ cells express MHC class II molecules, on day 1 post-injection (94.25+/23.3%) or 8 post-injection (87.65+/25.2%). A
representative dot plot is shown in F. G–H: When comparing injected EAE rats to injected control rats, data showed that on day 1 post-injection, a
greater pourcentage of CSFE
+ cells was detectable in the CLNs of injected EAE rats as compared to injected control rats (2.26+/20.11% vs 1.49+/
20.13% in injected EAE and injected control rats respectively, p=0.0339, Mann and Whitney test)(G). This difference did not reach significance on day
8 post-injection (1.71+/20.03% vs 1.66+/20.13% in injected EAE and injected control rats respectively) (H). *: p,0.05, NS: not significant.
doi:10.1371/journal.pone.0003321.g008
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order to better visualize red fluorescent microspheres on a black
background, red spots were represented as white spots. The
number and localization of CFSE
+ cells was assessed on serial
sections of different brain regions (anterior brain, midbrain,
brainstem and cerebellum) in EAE rats (n=8) or in control rats
(n=7). On sections obtained from animals sacrificed on day 1
post-injection (EAE rats: n=4, normal rats: n=4), a semi-
quantitative analysis was performed to evaluate the presence of
CFSE
+ cells in the following CNS compartments: intraventricular
CSF (free-floating or adherent to the choroid plexuses), periven-
tricular parenchyma, superficial meninges, deep-penetrating
meninges, perivascular spaces, CNS parenchyma. The following
semi-quantitative scale was used: 2: none, +/2: occasionnal cells,
+: 2 to 5 cells per section, ++: 5 to 10 cells per section, +++: more
than 10 cells per section. Also, the injected lateral ventricle was
specifically examined and the numbers of intraventricular vs
periventricular CFSE
+ cells were counted in EAE or control rats.
Finally, in EAE rats, sections crossing the injected lateral ventricle
(3 to 5 sections per animal, n=4 animals) were immunostained
with MBP and the number of CFSE
+ cells was counted in normal-
appearing or demyelinated periventricular white matter. Using a
computer-assisted system consisting (analysis auto, Soft Imaging
System GmbH, Munster, Germany), we then determined the
number of CFSE
+ cells per mm
2 surface in demyelinated vs non-
demyelinated periventricular white matter.
Electron microscopy
In some experiments, cervical lymph nodes obtained from
control EAE rats (n=3), EAE rats injected intra-CSF with
microspheres (n=4) or healthy control rats (n=3) were processed
for electron microscopy examination. Briefly, tissues were fixed for
30 min in 2% glutaraldehyde-0.1 M NaCacodylate pH 7.4. They
were then washed three times in 0.1 M NaCacodylate/sucrose,
pH 7.4 for 15 min and post-fixed with 1% OsO4-0.15 M
NaCacodylate pH 7.4 for 30 min. After dehydratation in a
growing gradient of ethanol, 5 min for each step: 30, 50, 70 and
95%, impregnation steps and inclusion were performed in Epon
Figure 10. DCs injected intra-CSF stimulates the antibody response against myelin oligodendrocyte glycoprotein. On day 20 post-
immunization, blood samples were withdrawn from control EAE rats (n=4) or EAE rats that had been injected intra-CSF with DCs on day 12 post-
immunization (n=4). Sera were then assessed by Western blot analysis or ELISA for the presence of antibodies directed against CNS antigens. A. The
serum antibody repertoire against whole spinal cord homogenate (obtained from healthy rats) was profiled by Western blot analysis (left panel)
followed by measures of optical densities (right panel). Data showed that, as compared to control EAE rats, sera from injected EAE rats contained
higher concentrations of antibodies directed against a 28 Kda protein, distinct from myelin basic protein (MBP, a major immunogenic myelin antigen)
(optic density: 5583.9+/21161.5 vs 2343+/2677 in EAE+DC and EAE rats respectively; p=0.0433, non parametric Mann and Whitney test). B. As
myelin oligodendrocyte glycoprotein (MOG, another major immunogenic myelin antigen) is a 28 Kda protein, we performed ELISA experiments
allowing serum antibodies against MOG peptide 35–55 to be measured. Data showed that higher concentrations of anti-MOG antibodies were
detectable in injected EAE rats (EAE+DCs) as compared to control EAE rats (EAE) (84.23+/222.8 ng/ml vs 20.53+/24.1 ng/ml in EAE+DCs vs EAE rats
respectively, p=0.0273, non parametric Mann and Whitney test). C. Western blot experiments (left panel) followed by quantitative analysis of optical
densities (right panel) showed that the serum antibody response against purified myelin basic protein (MBP) was not significantly different in EAE
injected rats (EAE+DCs) as compared to control EAE rats (EAE) (optic density: 20572+/21683.93 vs 18209+/22932.34 in EAE+DCs vs EAE rats
respectively, p: not significant). Membranes were stained with Red ponceau (lower left panel) to ensure that similar amounts of purified MBP had
been loaded in the different lanes. *: p,0.05.
doi:10.1371/journal.pone.0003321.g010
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obtained using an ultramicrotome RMC-MTX (Tucson), and
contrasted with uranyl acetate and lead citrate. Observations were
performed on a JEOL 1200EX transmission electron microscope
(Jeol LTD) equipped with a MegaView II high resolution TEM
camera and Analysis Soft Imaging system (Eloı ¨se SARL).
Flow cytometry
Following intra-CSF injection of CFSE-labeled DCs in normal
rats (n=7) or EAE rats (n=8), CLNs and axillary lymph nodes
were mechanically dissociated, washed once in PBS 16 then
filtered through a 70 mm cell strainer (Pharmingen, San Diego,
USA). Cells were then fixed in PFA 1% before analysis of CFSE
fluorescence. The level of autofluorescence was established on cells
obtained from the CLNs or ALNs of non-injected EAE rats or
control rats. Alternatively, cells were stained with OX6 antibody
(recognizing MHC Class II molecules) as previously described
[10]. Briefly, 2 to 5.10
5 cells were sequentially incubated on ice
with a blocking CD16/CD32 monoclonal antibody (Pharmingen,
San Diego, USA) and a mouse PE-conjugated OX6 antibody
(Pharmingen, San Diego, USA) diluted 1:50 in PBS containing 2%
FCS. After two washes in PBS 16, cells were then fixed in PFA
1% before being analyzed on a Galaxy flow cytometer (Partec,
Germany) with FlowMax software (Partec, Germany).
Western blot
Western blot experiments were performed to assess the presence
of serum antibodies directed against purified myelin basic protein
(MBP) (obtained from guinea pig brain, Sigma-Aldrich) or whole
spinal cord protein extracts (obtained from normal healthy rats).
Purified MBP or pooled spinal cord samples that had been boiled in
SDS-PAGE reducing buffer for 5 min at 95uC, were separated on a
SDS-PAGE gel and transferred onto a nitrocellulose membrane.
The membrane was incubated in PBS containing 0.1% Tween 20
and 5% milk, 1 h at room temperature and incubated with serum
samples (dilution 1/10) obtained from control EAE rats (n=4) or
EAE rats injected intra-CSF with DCs (n=4). Membranes were
then washed in PBS containing 0.1% Tween 20 and 1% Milk and
incubated with peroxidase-conjugated goat anti-rat IgG immuno-
globulin (Jackson, USA) for 1 hour at room temperature. After
washing, membranes were incubated with Western Blot Chemolu-
minescence Reagent (Covalab, France) for 1 min at room
temperature and blots were exposed to X-ray films. Semi-
quantitative analyses of signals were performed by measuring optical
densities with the software Image Quant.
ELISA
Serum samples were tested by ELISA for the presence of anti-
MOG 35–55 antibodies, using a commercially available kit
(Anaspec). Assays were performed in duplicate and according to
the manufacturer’s recommendations. Briefly, 100 ml of undiluted
serum samples were incubated in wells of the 96-well microtitra-
tion plate pre-coated with MOG 35–55 peptide and a blocking
solution. After washing, peroxidase-conjugated antibodies to rat/
mouse IgG were added and further incubated for 1 h at room
temperature. The reaction was developed after another series of
washes by addition of 50 ml of TMB (Tetramethylbenzidine) color
substrate solution. Optical densities were then measured on a
Multiskan EK ELISA spectrophotometer (Thermo Electron
Corporation, Courtaboeuf, France). A calibration curve was
established using standard dilutions of mouse anti-MOG IgG
and individual values of serum anti-MOG IgGs were then
calculated and expressed as ng/ml.
Statistical analyses
Statistical analyses were performed with the non-parametric
Mann and Whitney test. Alternatively, the Student’s t test was
performed when the n reached at least 10 in each group and only if
values had a Gaussian distribution as assessed by the Shapiro and
Wilk test.
Supporting Information
Data Supplement S1 Microspheres+/MBP+ cells in a periven-
tricular demyelinating lesion. EAE rats were injected intra-CSF
with fluorescent microspheres (red in A and D, white in C) and
were then sacrificed on day 8 post-injection. Brain sections were
immunostained with an anti-MBP antibody in order to visualize
myelin (green in A and D, white in B). Microphotograph in A
shows that a large demyelinated area adjacent to the third
ventricle, is filled with microspheres+ cells. Within this large
demyelinated area, a partially demyelinated area (solid square)
contains micropheres+/MBP+ cells. Higher magnification views of
this area are shown in B (MBP staining), C (microspheres) and D
(merge). V3: third ventricle. Scale bars: 100 mm (A), 10 mm (B–D)
Found at: doi:10.1371/journal.pone.0003321.s001 (0.92 MB TIF)
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